Inzidenz von metachronen Zweitkarzinomen nach Strahlentherapie in Kombination mit Platin und/oder Cetuximab bei Patienten mit Kopf-Hals-Tumoren.
Purpose: The second primary cancer (SPC) incidence after treatment with platinum-based chemotherapy and cetuximab in combination with radiotherapy has not been previously reported. Our aim was to compare SPC risk following radiotherapy in combination with these agents for the treatment of head and n...
| Publicado en: | Strahlentherapie und Onkologie Vol. 195; no. 6; pp. 468 - 475 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Jun2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |